Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127360341 | 12736034 | 1 | I | 20160215 | 20160912 | 20160912 | EXP | AU-PFIZER INC-2016097959 | PFIZER | 19.00 | YR | F | Y | 0.00000 | 20160912 | OT | GB | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127360341 | 12736034 | 1 | PS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | 75 UG, UNK | U | 72786 | 75 | UG | SOLUTION FOR INJECTION | ||||||
| 127360341 | 12736034 | 2 | SS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | 100 UG, UNK | U | 72786 | 100 | UG | SOLUTION FOR INJECTION | ||||||
| 127360341 | 12736034 | 3 | SS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | Intravenous (not otherwise specified) | 80 UG, UNK | U | 72786 | 80 | UG | SOLUTION FOR INJECTION | ||||||
| 127360341 | 12736034 | 4 | C | BUPIVACAINE. | BUPIVACAINE | 1 | Topical | 15 ML, UNK | 0 | 15 | ML | ||||||||
| 127360341 | 12736034 | 5 | C | CEFAZOLIN | CEFAZOLIN | 1 | Intravenous (not otherwise specified) | 1 G, UNK | 0 | 1 | G | ||||||||
| 127360341 | 12736034 | 6 | C | DEXAMETHASONE SODIUM PHOSPHATE. | DEXAMETHASONE SODIUM PHOSPHATE | 1 | 8 MG, UNK | 0 | 8 | MG | |||||||||
| 127360341 | 12736034 | 7 | C | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | 2 MG, UNK | 0 | 2 | MG | |||||||||
| 127360341 | 12736034 | 8 | C | ONDANSETRON | ONDANSETRON | 1 | 4 MG, UNK | 0 | 4 | MG | |||||||||
| 127360341 | 12736034 | 9 | C | PARECOXIB SODIUM. | PARECOXIB SODIUM | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 127360341 | 12736034 | 10 | C | PROPOFOL. | PROPOFOL | 1 | 125 MG, UNK | 0 | 125 | MG | |||||||||
| 127360341 | 12736034 | 11 | C | PROPOFOL. | PROPOFOL | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 127360341 | 12736034 | 12 | C | ROCURONIUM | ROCURONIUM BROMIDE | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 127360341 | 12736034 | 13 | C | ROCURONIUM | ROCURONIUM BROMIDE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 127360341 | 12736034 | 14 | C | SEVOFLURANE. | SEVOFLURANE | 1 | 0 | ||||||||||||
| 127360341 | 12736034 | 15 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 127360341 | 12736034 | 16 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 60 MG, UNK | 0 | 60 | MG | |||||||||
| 127360341 | 12736034 | 17 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 20 MG, UNK | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127360341 | 12736034 | 1 | Anaesthesia |
| 127360341 | 12736034 | 7 | Anaesthesia |
| 127360341 | 12736034 | 10 | General anaesthesia |
| 127360341 | 12736034 | 14 | Anaesthesia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127360341 | 12736034 | OT |
| 127360341 | 12736034 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127360341 | 12736034 | Hypoxia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |